Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Open House Pharmaceutical Department Treaties Tolvaptan, Except Medicines With Uniform Effects, Atc G04bx21 2025-09-15
Germany Conclusion Of A Non-exclusive Discount Agreement According To Section 130a Paragraph 8 Sgb V For The Active Ingredient Nomegestrol + Estradiol, Atc G03aa14 For The Period 01.08.25 - 31.07.27 (plus Extension Option 1x12 Months) Vgv Tender Dak-gesundheit 2025-09-15
Germany Conclusion Of A Non-exclusive Discount Agreement According To Section 130a Paragraph 8 Sgb V For The Active Ingredient Certolizumab Pegol, Atc L04ab05 For The Period 01.08.2025 - 31.07.2027 Vgv Tender Dak-gesundheit 2025-09-15
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Certolizumab Pegol, Atc L04ab05 For The Period 01.08.2025 - 31.07.2027 2025-09-15
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Felbamat, Atc N03ax10 For The Period 01.08.2025 - 31.07.2027 2025-09-15
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Ponesimod, Atc L04ae04 For The Period 01.08.2025 - 31.07.2027 2025-09-15
Norway 2632a Everolimus And Mycophenolic Acid (enterota Tablet) 2025-09-15
Norway 2632a Everolimus And Mykofenolic Acid (enterotablett) 2025-09-15
Sweden Injector To Pettracers Including Consumption 2025-09-15
France Framework Agreement For The Supply Of Dentretian Products And Equipment For The City Dalbertville 2025-09-15
Whats app